← All companiesTTravere Therapeutics, Inc.
TVTX - CIK 0001438533
Travere Therapeutics, Inc. net income by year
Travere Therapeutics, Inc. (TVTX) reported net income of -$25.55M for fiscal year 2025, as filed in its audited annual report with the SEC.
TVTX annual net income
TVTX net income 2012-2025
| Fiscal year | Net Income | Change |
|---|
| FY 2025 | -$25.55M | +92.1% |
| FY 2024 | -$321.55M | -188.6% |
| FY 2023 | -$111.40M | +60.0% |
| FY 2022 | -$278.48M | -54.6% |
| FY 2021 | -$180.09M | -6.3% |
| FY 2020 | -$169.43M | -15.7% |
| FY 2019 | -$146.43M | -42.6% |
| FY 2018 | -$102.68M | -71.9% |
| FY 2017 |
Net Income of similar companies
Frequently asked questions
How much profit does Travere Therapeutics, Inc. make?
Travere Therapeutics, Inc. (TVTX) reported net income of -$25.55M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has Travere Therapeutics, Inc.'s net income changed over time?
Between fiscal 2012 and fiscal 2025, Travere Therapeutics, Inc.'s net income declined from -$14.82K to -$25.55M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.